Scinai Immunotherapeutics (2F50) Cash flow

0 Followers

Scinai Immunotherapeutics Cash Flow

DE:2F50's free cash flow for Q2 2026 was $-2.61M. For the 2026 fiscal year, DE:2F50's free cash flow was decreased by $292.00K and operating cash flow was $-2.50M. See a summary of the company’s cash flow.

Cash Flow	Mar 26	Mar 25	Dec 23	Mar 23	Dec 21
Operating Cash Flow	$ -6.03M	$ -6.33M	$ -9.38M	$ -7.26M	$ -7.43M
Investing Cash Flow	$ -24.00K	$ -12.00K	$ -637.00K	$ -836.00K	$ -139.00K
Financing Cash Flow	$ 5.77M	$ 3.44M	$ 1.09M	$ 6.78M	$ 21.43M
End Cash Position	$ 1.81M	$ 2.10M	$ 5.01M	$ 14.21M	$ 17.52M
Free Cash Flow	$ -6.05M	$ -6.35M	$ -10.02M	$ -8.10M	$ -7.57M

Currency in USD